{"database": "openregs", "table": "documents", "rows": [["FDA-2011-N-0830-0028", "FDA", "FDA-2011-N-0830", "Reference 2-5 - U.S. Department of Health & Human Services, \u201cGuidance on Proper Consideration of Small Entities in Rulemakings of the U.S. Department of Health and Human Services,\u201d May 2003 re Abbreviated New Drug Applications and 505(b)(2) Applications", "Supporting & Related Material", "Background Material", "2016-10-06T04:00:00Z", 2016, 10, null, null, "2016-10-06T16:03:14Z", null, 0, 0, "09000064822a0d52"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-N-0830-0028"], "units": {}, "query_ms": 0.2243009948870167, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}